MARC details
000 -LEADER |
fixed length control field |
03021nam a22003137a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
220511s20222022 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
0041-1132 |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1111/trf.16871 [doi] |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
PMID |
35352362 |
245 ## - TITLE STATEMENT |
Title |
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?. |
251 ## - Source |
Source |
Transfusion. 2022 Mar 29 |
252 ## - Abbreviated Source |
Abbreviated source |
Transfusion. 2022 Mar 29 |
253 ## - Journal Name |
Journal name |
Transfusion |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Year |
2022 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Manufacturer |
FY2022 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Publication date |
2022 Mar 29 |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
Publication status |
aheadofprint |
266 ## - Date added to catalog |
Date added to catalog |
2022-05-11 |
520 ## - SUMMARY, ETC. |
Abstract |
Convalescent plasma, collected from donors who have recovered from a pathogen of interest, has been used to treat infectious diseases, particularly in times of outbreak, when alternative therapies were unavailable. The COVID-19 pandemic revived interest in the use of convalescent plasma. Large observational studies and clinical trials that were executed during the pandemic provided insight into how to use convalescent plasma, whereby high levels of antibodies against the pathogen of interest and administration early within the time course of the disease are critical for optimal therapeutic effect. Several studies have shown outpatient administration of COVID-19 convalescent plasma (CCP) to be both safe and effective, preventing clinical progression in patients when administered within the first week of COVID-19. The United States Food and Drug Administration expanded its emergency use authorization (EUA) to allow for the administration of CCP in an outpatient setting in December 2021, at least for immunocompromised patients or those on immunosuppressive therapy. Outpatient transfusion of CCP and infusion of monoclonal antibody therapies for a highly transmissible infectious disease introduces nuanced challenges related to infection prevention. Drawing on our experiences with the clinical and research use of CCP, we describe the logistical considerations and workflow spanning procurement of qualified products, infrastructure, staffing, transfusion, and associated management of adverse events. The purpose of this description is to facilitate the efforts of others intent on establishing outpatient transfusion programs for CCP and other antibody-based therapies. Copyright © 2022 AABB. |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
IN PROCESS -- NOT YET INDEXED |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
Washington Cancer Institute |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Journal Article |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Shenoy, Aarthi |
790 ## - Authors |
All authors |
Abinante M, Adamski J, Anjan S, Bloch EM, Broderick PB, Cachay ER, Casadevall A, Cruser D, Forthal D, Fukuta Y, Gawad A, Gebo KA, Gerber J, Gniadek TJ, Hanley DF, Heath SL, Huaman MA, Kafka K, Kassaye SG, Lane K, Levine A, Marshall C, McBee N, Meisenberg BR, Metcalf RA, Mosnaim GS, Patel B, Paxton JH, Raval JS, Reisler RB, Shenoy A, Shoham S, Sullivan D, Tobian AAR, Yarava A, Zand M, Ziman A |
856 ## - ELECTRONIC LOCATION AND ACCESS |
DOI |
<a href="https://dx.doi.org/10.1111/trf.16871">https://dx.doi.org/10.1111/trf.16871</a> |
Public note |
https://dx.doi.org/10.1111/trf.16871 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Journal Article |
Item type description |
Article |